Nxstage Pureflow Solution Rfp-209-Can 5.552 g (Sodium Chloride SOLUTION) 5.552 G

NXSTAGE PureFlow Solution RFP-209-CAN 5.552 G is a haemodialysis solution designed for use in renal therapy. This 5L solution contains sodium chloride and is manufactured by NXSTAGE Medical Inc.

Strength

5.552 G

Pack Size

Manufacturer / TM Owner

NXSTAGE MEDICAL INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NXSTAGE PureFlow Solution RFP-209-CAN 5.552 G is primarily used in haemodialysis to help filter waste and excess fluids from the blood. This process is essential for individuals with kidney dysfunction, as it mimics the natural function of healthy kidneys. The solution is formulated to support the dialysis process, aiding in the removal of toxins and maintaining electrolyte balance.

Side Effects

During haemodialysis, users may experience a range of effects, including changes in blood pressure and fluid balance. Some individuals might feel fatigued or lightheaded post-treatment. It's important to monitor these effects and consult with a healthcare provider if any concerns arise.

Precautions & Warnings

Handling NXSTAGE PureFlow Solution RFP-209-CAN 5.552 G requires adherence to sterile techniques to prevent contamination. Ensure the solution is stored as per manufacturer guidelines and used within its expiry date. Always follow the prescribed dialysis protocol and seek professional advice for any issues.

Avoid Interactions

NXSTAGE PureFlow Solution RFP-209-CAN 5.552 G may interact with other medications or substances used during dialysis. It's crucial to inform healthcare providers about all medications being taken to avoid potential interactions. Always use the solution as directed by a healthcare professional.

Frequently Asked Questions

This solution is used in haemodialysis to help filter waste and excess fluids from the blood, supporting kidney function.

Store the solution according to the manufacturer's guidelines to maintain its efficacy and sterility.

Users may experience changes in blood pressure, fluid balance, and fatigue post-treatment.

Yes, it may interact with other medications or substances used during dialysis. Consult a healthcare provider for guidance.

Safety depends on individual health conditions. Always follow the advice of a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.